The Interferon-inducible NAMPT acts as a protein phosphoribosylase to restrict viral infection

Shu Zhang,Na Xie,Yongzhen Liu,Chao Qin,Ali Can Savas,Ting-Yu Wang,Shutong Li,Youliang Rao,Alexandra Shambayate,Tsui-Fen Chou,Charles Brenner,Canhua Huang,Pinghui Feng
DOI: https://doi.org/10.1101/2023.10.12.562112
2023-10-16
bioRxiv
Abstract:As obligate intracellular pathogens, viruses often activate host metabolic enzymes to supply intermediates that support progeny production. Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the salvage NAD+ synthesis, is an interferon-inducible protein that inhibits the replication of several RNA and DNA viruses with unknown mechanism. Here we report that NAMPT restricts herpes simplex virus 1 (HSV-1) replication via phosphoribosyl-hydrolase activity toward key viral structural proteins, independent of NAD+ synthesis. Deep mining of enriched phosphopeptides of HSV-1-infected cells identified phosphoribosylated viral structural proteins, particularly glycoproteins and tegument proteins. Indeed, NAMPT de-phosphoribosylates viral proteins in vitro and in cells. Chimeric and recombinant HSV-1 carrying phosphoribosylation-resistant mutations show that phosphoribosylation promotes the incorporation of structural proteins into HSV-1 virions and subsequent virus entry. Moreover, loss of NAMPT renders mice highly susceptible to HSV-1 infection. The work describes a hidden enzyme activity of a metabolic enzyme in viral infection and host defense, offering a system to interrogate roles of phosphoribosylation in metazoans.
What problem does this paper attempt to address?